How Much Peptide Sequence Information Is Contained in Ion Trap Tandem Mass Spectra?  by Cox, Jürgen et al.
FOCUS: PEPTIDE FRAGMENTATION
How Much Peptide Sequence Information Is
Contained in Ion Trap Tandem Mass Spectra?
Jürgen Cox, Nina C. Hubner, and Matthias Mann
Department for Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry,
Martinsried, Germany
Matching peptide tandem mass spectra to their cognate amino acid sequences in databases is
a key step in proteomics. It is usually performed by assigning a score to a spectrum-sequence
combination. De novo sequencing or partial de novo sequencing is useful for organisms
without sequenced genome or for peptides with unexpected modifications. Here we use a very
large, high accuracy proteomic dataset to investigate how much peptide sequence information
is present in tandem mass spectra generated in a linear ion trap (LTQ). More than 400,000
identified tandem mass spectra from a single human cancer cell line project were assigned to
26,896 distinct peptide sequences. The average absolute fragment mass accuracy is 0.102 Da.
There are on average about four complementary b- and y-ions; both series are equally
represented but y ions are 2- to 3-fold more intense up to mass 1000. Half of all spectra contain
uninterrupted b- or y-ion series of at least six amino acids and combining b- and y-ion information
yields on average seven amino acid sequences. These sequences are almost always unique in the
human proteome, even without using any precursor or peptide sequence tag information. Thus,
optimal de novo sequencing algorithms should be able to obtain substantial sequence information
in at least half of all cases. (J Am Soc Mass Spectrom 2008, 19, 1813–1820) © 2008 Published by
Elsevier Inc. on behalf of American Society for Mass SpectrometryIn “bottom up” MS-based proteomics, proteins aredigested to peptides that are then mass measured,isolated in the mass spectrometer, and fragmented,
leading to characteristic ion series in the MS/MS spec-
tra [1, 2]. Popular database search programs like Mascot
[3], Sequest [4], and many others score these MS/MS
spectra against in silico digested peptides whose calcu-
lated precursor masses fall into a suitable window
around the measured mass, leading to statistically sig-
nificant identification for a fraction of the mass spectro-
metric sequencing events [5]. In most cases, the propor-
tion of identifiable peptides is quite low for samples of
high protein complexity [6]. Despite recent improve-
ments in identification rates [7, 8], many MS/MS spec-
tra remain unassigned, even though they are of reason-
able quality.
The peptide database search approach has the dis-
advantage that it is blind towards the unexpected: only
peptides that result from the digestion of known pro-
tein sequences, possibly having a few missed cleavages
and a very limited number of standard variable modi-
fications, can be identified in this way. The sequence tag
approach [9] is an alternative to the conventional pep-
tide database search that does not suffer from these
limitations. Instead of operating in the restricted space
of in silico digestions of known protein sequences, one
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doi:10.1016/j.jasms.2008.07.024starts by looking for a series of peaks that correspond to
consecutive members of a fragment series. Each of the
mass differences between two neighboring peaks must
be equal to one of the 20 amino acid masses. Much of
the specificity of a sequence tag in database searches
comes from the mass information encoded in the two
flanking masses. In this way, even a tag of two or three
amino acids is usually unique in the proteome, espe-
cially given the very high precursor mass accuracy
possible with modern, high-resolution mass spectrom-
eters. A tag sequence that is part of an in silico peptide
but with a wrong parent mass points to a novel and
potentially interesting modification or mutation, while
a sequence tag that does not match any in silico peptide
might be evidence for the expression of a novel and
not-predicted protein.
The de novo sequencing problem consists of finding
the correct amino acid sequence from the tandem mass
spectrum without the help of a database. This problem
has fascinated mass spectrometrists for at least three
decades and is still not completely solved. Until re-
cently, algorithms have been developed on the basis of
restricted datasets. Even the latest efforts in de novo
sequencing, i.e., the work of the Pevzner group [10, 11],
have not yet taken advantage of recent improvements
in performance and in the size of datasets. A fundamen-
tal question in the development of partial or complete
de novo sequencing algorithms is how much informa-
tion is present in tandem mass spectra as generated by
state of the art proteomics projects. Determination of
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1814 COX ET AL. J Am Soc Mass Spectrom 2008, 19, 1813–1820contiguous peptide sequence generally requires the
presence of a fragmentation product from each amino
acid bond. Here we set out to determine how often this
information is present in tandem mass spectra in very
large proteomics projects. We use a large-scale dataset
from our group [7], which was analyzed with the
MaxQuant set of algorithms [12] and the Mascot search
engine. MaxQuant uses the entire mass information
present in all survey (precursor) mass spectra and
employs sophisticated, peptide length dependent scor-
ing statistics. As a result, the requirements for tandem
mass spectra data quality are substantially reduced
compared with standard database search, and more
than 50% of the fragmentation events are generally
assigned in any dataset. We use this very large and high
quality dataset to determine the peptide sequence in-
formation in linear ion trap fragmentation data. We find
that substantial sequence information is embedded in
the majority of tandemmass spectra and we extrapolate
these results to similar quality tandemmass spectra that
are not identified by standard search engines.
Experimental
Methods
Mass spectrometric data. We used the dataset from Cox
andMann [7], which was generated with SILAC labeled
HeLa cells after EGF stimulation. Briefly, triplicates
were separated into 24 isoelectric focusing fractions,
which were analyzed with nanoLC-MS on an LTQ
Orbitrap mass spectrometer. MS scans were acquired
with high resolution (60,000 at m/z 400), and mass
accuracy at the precursor ion level was extremely high,
with an average absolute mass deviation of less than
300 ppb. Peptide identification additionally relied on
the SILAC information present. Presence of a SILAC
pair implies that the peak represents a peptide and not
a contaminant molecule. Furthermore, the number of
arginines and lysines is known before database search
for SILAC pairs. MS/MS spectra were obtained at low
resolution in linear ion trap mode and written out as
centroid data. These spectra were filtered by retaining
only the six most intense peaks in each 100 Th interval
[13]. Fragment ions were matched with 0.5 Th mass
tolerance. The international protein index (IPI) [14]
human version 3.37 served as the sequence database.
Processing of the 72 raw files with our MaxQuant
software [12] leads to 461,336 identified MS/MS spectra
at a 1% false discovery rate (FDR). For the sake of
simplicity, we restrict our analysis to the 428,567 of
these MS/MS spectra that correspond to completely
unmodified peptides, accepting both light and heavy
SILAC labeled forms. Together they identify 26,896
distinct peptide sequences with a length of at least six
amino acids.
As indicated in the text, in some analyses unfiltered
tandem mass spectra were used. The same data were
processed but without the filtering of MS/MS spectra in100 Th bins before submission to the database engine
search. In this case, 428,567 MS/MS spectra correspond-
ing to unmodified peptides were identified at 1% FDR,
corresponding to 16,853 distinct peptide sequences.
Uniqueness of partial sequences in the human proteome and
genome. The partial sequences from the approaches
with and without MS/MS filtering were merged. All
sub-sequences in identified partial sequences were also
considered as partial sequences. For the determination
of the multiplicity of partial sequences in the hu-
man proteome, we counted their occurrence in the
ENSEMBL protein predictions, which attempts to pro-
vide a nonredundant set of sequences for the human
genome [15]. To avoid underestimation of uniqueness
due to the presence of protein isoforms we considered
only one protein sequence for each ENSEMBL gene
identifier, namely the longest one. The combinations of
amino acids with the same molecular weight (leucine
and isoleucine) and the same nominal weight (lysine
and glutamine) were considered distinct for this calcu-
lation. For the statistics over the whole human genome,
we downloaded all six frame translations of all human
chromosomes from http://www.stateslab.org/data/
6frameorfs/index.htm.
Results and Discussion
Fragment Mass Accuracy, Charge Distribution,
and Fragment Mass Filtering
We first used our large dataset to determine average
fragment mass accuracy. Figure 1a shows a histogram
of the difference between measured and calculated
fragment ion masses derived from several million
matched fragments. The average absolute mass devia-
tion in this histogram is 0.102 Da. The distribution is
centered at zero indicating good calibration. All but 5%
of fragments are measured within 0.3 Da of the true
value and 99% within 0.42 Da. The graph indicates that
the commonly used maximum mass deviation [16]
of 0.5 Da for ion trap fragments encompasses close to
100% of measured fragment ions. On the basis of these
results, would it be advantageous to set the fragment
mass window more tightly? The answer is no, because
fragment ion masses—particularly below 1000 Da—are
confined to small bands of possible masses, given the
restricted atomic composition of amino acids [17]. With
the mass accuracy achieved in this dataset, there is
virtually no chance that an observed fragment can be
matched to a calculated fragment with a different
nominal mass. This is of course only true for low-
resolution ion trap data. High-resolution MS/MS data,
i.e., by measuring the fragments in the Orbitrap,
achieves low ppm mass accuracy. This high-resolution
data additionally eliminate almost all incorrect frag-
ment matches with the same nominal mass.
In Figure 1b the charge distribution of identified
peptides is shown. About three-quarters of the tryptic
spectrum.
1815J Am Soc Mass Spectrom 2008, 19, 1813–1820 SEQUENCE CONTENT OF TANDEM MASS SPECTRApeptide precursors are doubly charged, and 22% are
triply charged. Only 2% are quadruply or higher
charged. (Singly charged ions were excluded from
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Figure 1. Properties of identified MS/MS spectra. (a) Histogram of
measured minus calculated m/z of all matched fragment ion peaks.
The average absolute mass deviation is 0.102, which fits well with the
search tolerance of0.5 Da used in the database search. (b) Mass and
charge distributions of the precursor peptides. (c) The average
number of peaks per 100 Th mass interval in MS/MS spectra is
plotted as a function of m/z for the unfiltered data (red) and for the
data filtered to have at most six peaks per 100 Th interval (blue).sequencing.)0
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Figure 2. Statistics of fragment ions. (a) Total counts of fragment
ion peaks matched in the identified MS/MS spectra correspond-
ing to unmodified peptides separately for b-ions (red), y-ions
(green), and y2-ions (blue). (b) Average normalized intensity of
the fragment ion peaks. The intensities have been normalized in
each MS/MS spectrum such that the highest matched peak has
intensity one. (c) Distribution of the number of complementary
ions per peptide. Two ions bm and yn are complementary if m  n
equals the length of the peptide sequence. On average about four
complementary ion pairs are contained in each filtered MS/MS
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values due to fragmentation events leading to ions
different from b- or y-ion types or chemical or electronic
noise. These uninformative peaks would make identifi-
cation difficult, and they are generally of lower abun-
dance than sequence specific fragments. Therefore,
spectra are frequently “filtered” so that only the most
intense ions remain [18]. Depending on the application
we have found a “top 4 filter” per 100 Th or a “top 6
filter” advantageous in separating signal (high inten-
sity) from noise (low intensity). Here we chose a “top 6
filter”. As can be seen in the blue curve in Figure 1c,
there are usually enough signals in this centroided data
that six masses can be obtained in each 100 Th interval,
especially at masses below 1000. We also analyzed
unfiltered data. Here we obtain signals at up to 60% of
all nominal mass values—this number slowly declines
to less than 30% at mass 1000 (red curve in Figure 1c).
Properties of Identifiable Tandem Mass Spectra
As mentioned above, our dataset contains low quality
MS/MS spectra that are nevertheless unambiguously
identified due to the SILAC information and the ex-
tremely high precursor mass accuracy. Figure 2a shows
a histogram of the three major ion series, b-ions, y-ions,
and y2-ions. The number of fragments for each index
(i.e., index of y6 ion is 6) is a smooth function that for
y-ions increases to a maximum at y8 after which it
declines to a few percent of this maximum around y15.
Note that this distribution is a convolution of the actual
number of fragments of a peptide of length n with the
distribution of peptide lengths (Figure 1b). Surpris-
ingly, there are almost as many b-ions as there are
y-ions. As expected [19], the b1 ion is not observed and
the b2 ion is the most frequent one. After this the
distribution of b-ions decreases until b4, where it stays
about constant until it catches up to the number of
y-ions at b11/y11. The doubly charged y-ion series starts
at y6 and continues relatively flat until y18. However, it
is a minor number compared with either b-ions or
y-ions.
In Figure 2b, we have plotted the average intensity of
each ion index, normalized to the largest peak in the
tandem mass spectrum. Here, the difference between b-
and y-ion series is much more pronounced. The y-ions
are up to three times more intense compared with
b-ions, particularly in the “tag region” of y4 to y8. This
may partly account for the fact that it is often very easy
to define a partial sequence of three to four y-ions in
any spectrum. (This is even more true in “triple quad-
rupole type” spectra in which b-ions tend to fragment
further.) Unexpectedly, the y2 series, despite its infre-
quent presence, is as intense as the most abundant
y-ions and much more intense than b-ions on average.
One of the major challenges in de novo sequencing is
to avoid connecting fragments from different series.
Complementary ions (N- and C-terminal ions from the
same position in the peptide sequence) can help definethe nature of each ion series or at least distinguish one
from the other in de novo sequencing algorithms.
Furthermore, complementary ion pairs are more likely
to be genuine fragment peaks rather than noise or
internal fragments and they therefore provide excellent
“anchor sites”. We counted the number of complemen-
tary ion pairs in all spectra and found that on average
there are about four (Figure 2c). This indicates that
preprocessing of tandem mass spectra for such pairs is
a generally useful first step in spectral interpretation.
Note, however, that the presence of a pair of comple-
mentary fragment masses is not an absolute indication
that they are actually a pair: for each given b- or y-ion
there is a 6% chance of finding a complementary ion by
chance as 6% of all mass values have a signal after “top
6 filtering”.
Occurrence of Partial Sequences
In the set of all unmodified peptides (461,336 spectra),
we looked for consecutive stretches in the singly and
doubly charged y- and in the singly charged b-ion series
using the results of the prior database search. An ion
fragment series consisting of i  1 peaks determines a
(partial) sequence of length i. If we speak of a sequence
of length i we mean a series of i amino acids defined by
i  1 peaks. Note that the length of sequences present in
the spectrum depends on the depth of filtering. All
numbers given here are for the top 6 filter per 100 Th.
Figure 3a provides an example of a tandem mass
spectrum in which partial sequences have been as-
signed. It contains two sequences of length 3 and 7 in
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Figure 3. MS/MS spectrum with partial sequences. (a) MS/MS
spectrum identifying the peptide LQAYHTQTTPLIEYYR with a
Mascot score of 86.4. It contains four partial sequences. (b) Zoom
into the range 700–1000 Th, showing the y , which is clearly6
present but was excluded during “top 6 filtering”.
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in the b-ion series. The longest sequence is AYHTQTT.
Figure 3b indicates the presence of the missing frag-
ment ion between the two y-ion sequences within the
low abundance peaks (outside of the top 6 per 100 Th).
With this fragment the partial sequence becomes
AYHTQTTPLIEY, indicating that the low abundance
peaks can be important (see also below).
Starting with i 1, we find 263,142 partial sequences
in total, of which 116,254 belong to the b-ion series,
122,708 belong to the y-ion series, and 24,180 belong to
the y2 series. To investigate the effects of removing
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1818 COX ET AL. J Am Soc Mass Spectrom 2008, 19, 1813–1820quences are longer than b-ion sequences on average.
Sequences in doubly charged series constitute only a
small fraction of the total. We reasoned that some
partial sequences may be extendable when connecting
between the three ion series. The result of this analysis
is plotted in Figure 4b. Indeed, sequences are on aver-
age longer by one amino acid when considering all
three ion series together. Furthermore, the decay to long
sequences is shallower.
When using unfiltered MS/MS spectra, there is a
sharp increase in the long sequences, in particular for
the ones belonging to the b-series (Figure 3c). Sequences
from doubly charged ions increase in absolute numbers
as well. This indicates that for some partial sequences
found in the filtering approach there are peaks present
at low abundance that could either extend or join the
sequences consisting of high abundance fragments.
Many long b and charge two sequences appear to be
present in the data but get shortened or interrupted by
the filtering. However, this is difficult to state with
certainty because of the high density of peaks in the
unfiltered data (Figure 1c), which presents many oppor-
tunities to randomly connect fragment ion series.
In Figure 4d, the number of peptides containing a
partial sequence of at least length x in any of the three
ion series is shown as a function of x. More than 85% of
all identified peptides have a tandem spectrum that
contains a partial sequence of at least three amino acids,
and half of the peptides have spectra that contain a six
amino acid fragment sequence. Combining all three ion
series and performing the same analysis (Figure 4e)
yields sequences that are on average one amino acid
longer (just as when counting total sequence occurrence
in Figure 4b). Finally, we investigated how many pep-
tides have spectra with partial fragment sequences of
length x for unfiltered data. As can be seen in Figure 4f,
almost all of these peptides contain sequences of at least
6 amino acids and half of them contain sequences of 9
amino acids.
Uniqueness of Short Peptide Sequences in the
Human Proteome and Genome
We next investigated the usefulness of the partial pep-
tide sequences contained in most tandem mass spectra
in locating the corresponding site encoding the peptide
in the human proteome. For this purpose, we prepared
a database containing a single transcript per entry in the
ENSEMBL database (see the Experimental section). One
can see in Figure 5 that partial sequences of length 4 or
shorter are virtually never unique. Partial sequences of
four amino acids occur on average in about 100 candi-
date positions in the proteome. Going to length 5
reduces the number of candidates to 10 on average and
5% of tags are unique in the proteome. A sharp increase
in uniqueness follows, and partial sequences of length 7
are already unique in most cases. Here we ignore the
non-uniqueness due to proteins that result from alterna-tive splicing of the same gene by selecting for each gene
only the isoform with the longest sequence. One would
expect that long partial sequences would become com-
pletely unique in the proteome. This is, however, not
the case; instead, a plateau is reached at about 86%. This
is due to the presence of proteins encoded at different
gene locations with a high pair-wise sequence similarity,
or also due to highly conserved protein domains. For
instance, the sequence TGIVMDSGDGVTHTVPIYEGYAL
that is found in our dataset should be highly unique.
However, we find that it is contained in two protein
sequences encoded by two different genes, -actin
(ACTB) and -actin (ACTG1), which are located on
different chromosomes. Both proteins have a length of
375 amino acids and their sequences differ only at four
positions.
Figure 5c shows the histogram of occurrence in the
proteome for partial sequences of length 5, 6, and 7. For
sequences of length 5, there is still a small fraction that
match 10 or more times in the proteome, while for
sequences of length 6, half are already unique. For
length 7, three-quarters are unique and almost all others
only occur twice. Thus, there is little need to de novo
sequence more than seven amino acids to uniquely
“lock down” the peptide in the human proteome.
However, for organisms without sequenced genome,
longer amino acid sequences may be desired for homol-
ogy searching or cloning.
Partial sequences of length 3 or 4 usually occur in 100
to 1000 locations in the human proteome. While this
may appear to be a very large number, it is actually very
manageable for computer algorithms. Just like in the
peptide sequence tag approach, these loci can be ex-
panded in N- and C-terminal direction to obtain a mass
match. With only 1000 “seed points” and very high
precursor mass accuracy, a very large number of pos-
sibilities can be tried to obtain a fit to the measured
precursor mass and to the maximum number of mea-
sured fragments. Thus, far from being useless, even
very short partial sequences should be able to allow
unique reconstruction and matching of both the modi-
fied and unmodified peptides.
Searching the partial sequences in a complete six
frame translation of the human genome resulted in
similar patterns as for the proteome. However, due to
the larger search space, partial sequences on average
had to be longer by two amino acids for the same
degree of uniqueness (Figure 5).
Conclusions and Perspectives
Here we have shown that tandem mass spectra from
large proteomics projects are surprisingly rich in se-
quence information. A majority of spectra contains the
fragment ions necessary to yield useful sequences.
On-going advances in algorithm design, combined with
progress in the theoretical understanding [20] and em-
pirical modeling [21] of peptide fragmentation, should
1819J Am Soc Mass Spectrom 2008, 19, 1813–1820 SEQUENCE CONTENT OF TANDEM MASS SPECTRAmake it possible to reliably “read out” these sequences
from most of the spectra.
There are several obvious directions for future im-
provements of the data to assists de novo or partial de
novo algorithms. One is the use of high-resolution and
high mass accuracy in tandem mass spectra. As the
required ions are usually present even in large datasets
(as shown here), they could be unambiguously identi-
fied if sensitivity and dynamic range of MS/MS mea-
surement in a high accuracy setting was improved to
approach that of the ion trap. On the LTQ-Orbitrap
instrument, a particularly attractive option would be
the use of higher energy dissociation (HCD), which
does not have a low mass cut-off and which produces
“triple quadrupole”-like fragmentation with long y-ion
series [22].
Another direction is the more discriminating assign-
ment of peaks in the current low-resolution tandem
mass spectra. If the raw data, rather than the centroided
data, could be saved, one could employ much more
sophisticated algorithms for peak detection than are
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